Health Catalyst (HCAT) Announces Proposed $225M Share Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- Fed’s Warsh says central bank won’t tolerate high inflation
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- IBM misses Q2 targets as mainframe and software sales disappoint
- Verizon planning new round of layoffs this week - Barron’s
- Goldman Sachs Upgrades NIO (NIO) to Buy
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
Health Catalyst (HCAT) Prices 4.25M Share Offering at $53/sh
August 11, 2021 5:44 AM EDTHealth Catalyst, Inc. (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the pricing of an underwritten public offering of 4,245,283 shares of its common stock at a public offering price of $53.00 per share. The gross proceeds to Health Catalyst from the offering are expected to be approximately $225.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Health Catalyst. In addition, Health Catalyst has granted the underwriters a 30-day option to purchase up to an... More
Health Catalyst Inc. (HCAT) PT Raised to $66 at Piper Sandler
August 6, 2021 9:06 AM EDTPiper Sandler analyst Sean Wieland raised the price target on Health Catalyst Inc. (NASDAQ: HCAT) to $66.00 (from $57.00) while maintaining a Overweight rating.... More
Health Catalyst Inc. (HCAT) PT Raised to $66 at Stifel
August 6, 2021 8:58 AM EDTStifel analyst David Grossman raised the price target on Health Catalyst Inc. (NASDAQ: HCAT) to $66.00 (from $57.00) while maintaining a Buy rating.... More
Health Catalyst Inc. (HCAT) PT Raised to $64 at Canaccord Genuity
August 6, 2021 7:42 AM EDTCanaccord Genuity analyst Richard Close| raised the price target on Health Catalyst Inc. (NASDAQ: HCAT) to $64.00 (from $60.00) while maintaining a Buy rating.... More
